Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation
Open Access
- 4 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 100 (5), 1283-1293
- https://doi.org/10.1007/s00277-021-04454-7
Abstract
BK virus is one of the most common causes of hemorrhagic cystitis (HC) in children undergoing hematopoietic cell transplantation (HCT). Viruses can be found in urine and serum samples of immunocompromised patients. Malignant diseases, age, cell source, day of granulocyte reconstitution, conditioning regimen, or use of total body irradiation may play an important role in BKV epidemiology, development of hemorrhagic cystitis course, and outcome. The aim of this study was to evaluate the incidence, clinical course, and risk factors for BKV-HC in children undergoing HCT. A total number of 133 patients who were prospectively tested for BKV colonization/infection were enrolled into this multicenter analysis. Episodes of BKV-HC occurred in 36/133 (27%) enrolled subjects. In a univariate analysis for BKV-HC incidence, the following factors were significant: age >5 years, peripheral blood transplantation, matched unrelated donor (MUD) transplantation, busulfan-cyclophosphamide-melphalan conditioning regimen, and acute myeloblastic leukemia (AML) diagnosis. Presence of acute graft-versus-host disease (aGVHD) in liver and gut GVHD was a significant risk factor of BKV-HC. No BKV-attributed deaths were reported. In multivariate analysis, the incidence of HC was significantly higher in patients with AML, age >5 years, MUD transplants, and children with GVHD. HC is a frequent complication after HCT among children causes prolonged hospitalization but rarely contributes to death. We identified risk factors of BKV-HC development in children, with focus on aGVHD: we concluded that excessive immune reaction connected with GVHD and immunosuppression drugs might play a pivotal role in the development of BKV-HC.Keywords
This publication has 54 references indexed in Scilit:
- Efficacy and Safety of Leflunomide for the Treatment of BK Virus-Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation RecipientsActa Haematologica, 2013
- Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor typeHaematologica, 2010
- Relationship of Pretransplantation Polyoma BK Virus Serologic Findings and BK Viral Reactivation after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2007
- Acyclic nucleoside phosphonates: a key class of antiviral drugsNature Reviews Drug Discovery, 2005
- Incidence, Clinical Outcome, and Management of Virus-Induced Hemorrhagic Cystitis in Children and Adolescents after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2005
- Cyclophosphamide-induced hemorrhagic cystitis successfully treated with conjugated estrogensAmerican Journal of Hematology, 2005
- Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type mattersBlood, 2004
- Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantationBone Marrow Transplantation, 2002
- Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydrationBone Marrow Transplantation, 1999
- Association of BK Viruria with Hemorrhagic Cystitis in Recipients of Bone Marrow TransplantsThe New England Journal of Medicine, 1986